Video

John McDermott, Quotient Sciences, discusses the unique benefits of Translational Pharmaceutics

Watch Video

John McDermott, Quotient Sciences, discusses the unique benefits of Translational Pharmaceutics

John McDermott, Executive Director, Drug Development Solutions - Quotient Sciences discusses Translational Pharmaceutics at CPhI Worldwide, and how a recent Tufts study has proven the significant savings and financial benefits for drug developers who use Translational Pharmaceutics.